Global Chemotherapy-Induced Anemia Market Growth Overview For 2024-2033

The Business Research Company’s Chemotherapy-Induced Anemia Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 28, 2024 /EINPresswire.com/ -- The chemotherapy-induced anemia market has shown robust growth, expanding from $2.4 billion in 2023 to $2.6 billion in 2024 at a CAGR of 8.4%. This growth is driven by increased cancer prevalence, expanded chemotherapy treatments, and an aging population with higher cancer incidence. The market is poised to grow to $3.46 billion by 2028, at a CAGR of 7.4%, supported by advancements in oncology supportive care, rising healthcare expenditure, and personalized medicine.

Rising Prevalence of Cancer and Chemotherapy Driving Market Growth
The high prevalence of cancer and chemotherapy-induced anemia (CIA) are significant factors propelling market expansion. CIA occurs due to inflammation-induced iron deficiency, bone marrow disruption, and malignant tissue invasion, leading to blood loss.

Explore comprehensive insights into the chemotherapy-induced anemia market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12513&type=smp

Major Players and Market Trends
Key players such as Pfizer Inc., Johnson & Johnson, and Novartis AG are focusing on developing oral treatments like oral HIF-PHI to enhance red blood cell production. For example, FibroGen Inc.'s roxadustat showed promising results in treating CIA, demonstrating efficacy in non-myeloid malignancies without the need for red blood cell transfusions.

Market Segments
•Anemia Types: Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia
•Treatment Types: RBC Transfusion, Erythropoiesis-Stimulating Agents (ESAs), Iron Supplementation
•End-Users: Hospitals, Ambulatory Surgical Centers, Multispecialty Clinics, Cancer Research Centers, Cancer Rehabilitation Centers

Regional Insights: North America Leads, Asia-Pacific to Witness Rapid Growth
North America dominated the chemotherapy-induced anemia market in 2023, driven by advanced healthcare infrastructure and high healthcare expenditure. Asia-Pacific is expected to witness the fastest growth, supported by increasing cancer incidences and improving healthcare facilities.

Make your report purchase here and explore the whole industry's data as well
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Chemotherapy-Induced Anemia Global Market Report 2024 from TBRC covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Chemotherapy-Induced Anemia Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on chemotherapy-induced anemia market size, chemotherapy-induced anemia market drivers and trends, chemotherapy-induced anemia market major players, competitors' revenues, market positioning, and market growth across geographies. The chemotherapy-induced anemia market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Immuno-Oncology Drugs Global Market Report 202
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Interventional Oncology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn